ACI-7104

N/A

Report date: 2024/01/04 17:19:36

Base Information

Drug NameACI-7104
Drug Alias NameACI-7104ACI-7104.056
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsSynuclein alpha inhibitors
TargetsSynuclein alpha
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyUnited KingdomSpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAc Immune Sa
China Registration ClassN/A

Develop Information

Active CompaniesAc Immune Sa
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A